Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mario Gabelli Adds to Activist Position in Rochester Medical Corporation

Mario Gabelli of Gamco Investors has recently added to his activist position in Rochester Medical Corporation (NASDAQ:ROCM). In a recent 13D filing with the SEC, Gamco disclosed ownership of about 528,200 shares of the company, with the value of the stake amounting to some $10.5 million at the current price of Rochester Medical’s stock. This means that in comparison with the end of the previous quarter, Gamco added around 17,700 shares to its position in the company.

Mario Gabelli

The move in Rochester Medical is interesting, since during the past two quarters Gabelli’s hedge fund has been unloading shares of the company. However, the purchase of additional shares can be explained, since it comes amid the recent announcement that C.R. Bard, Inc. (NYSE:BCRwill buy the company for a little over $260 million. Rochester Medical will be acquired by C.R Bard at a price of $20 per share. At a current price of $19.92, most of the merger arbitrage opportunity has dried up.

Still it’s worth noting that Grt Capital Partners, Jim Simons’ Renaissance Technologies and Algert Coldiron Investors are also invested in the merger arb play alongside Mario Gabelli and Gamco Investors.

Recommended Reading:

Is Leap Wireless a Good Investment?

Mario Gabelli: iGo, Inc. (IGOI) & Pre-Merger Intermec Inc. (IN)

Mario Gabelli On Tesla Motors & Elon Musk

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.